MPT: Genetic Testing Aids in Anticoagulant Selection in ACS

ACC Conference Reporter

ACC.18 | ORLANDO, FL — A personalized, genomics-based approach to selecting antiplatelet therapy led to a clinically meaningful reduction in ischemic and bleeding events in acute coronary syndrome (ACS) patients, researchers reported here. Read More >>>

Keywords: ACC18, ACC Annual Scientific Session

< Back to Listings